Kabra Drugs informs about standalone financial results

15 Nov 2016 Evaluate

Kabra Drugs has informed about Standalone Financial Results for the period ended September 30, 2016 and Standalone Limited Review for the period ended September 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

26.95 -0.03 (-0.11%)
22-Jan-2026 10:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1640.35
Dr. Reddys Lab 1219.35
Cipla 1380.00
Zydus Lifesciences 885.90
Lupin 2188.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×